These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 10391558)
1. K-ras and p53 mutations in the pathogenesis of classical and goblet cell carcinoids of the appendix. Ramnani DM; Wistuba II; Behrens C; Gazdar AF; Sobin LH; Albores-Saavedra J Cancer; 1999 Jul; 86(1):14-21. PubMed ID: 10391558 [TBL] [Abstract][Full Text] [Related]
2. Genetic alterations in goblet cell carcinoids of the vermiform appendix and comparison with gastrointestinal carcinoid tumors. Stancu M; Wu TT; Wallace C; Houlihan PS; Hamilton SR; Rashid A Mod Pathol; 2003 Dec; 16(12):1189-98. PubMed ID: 14681318 [TBL] [Abstract][Full Text] [Related]
3. Appendiceal goblet cell carcinoids and adenocarcinomas ex-goblet cell carcinoid are genetically distinct from primary colorectal-type adenocarcinoma of the appendix. Jesinghaus M; Konukiewitz B; Foersch S; Stenzinger A; Steiger K; Muckenhuber A; Groß C; Mollenhauer M; Roth W; Detlefsen S; Weichert W; Klöppel G; Pfarr N; Schlitter AM Mod Pathol; 2018 May; 31(5):829-839. PubMed ID: 29327707 [TBL] [Abstract][Full Text] [Related]
4. Alteration of the p53 tumor suppressor gene occurs independently of K-ras activation and more frequently in serous adenocarcinomas than in other common epithelial tumors of the human ovary. Fujita M; Enomoto T; Inoue M; Tanizawa O; Ozaki M; Rice JM; Nomura T Jpn J Cancer Res; 1994 Dec; 85(12):1247-56. PubMed ID: 7852189 [TBL] [Abstract][Full Text] [Related]
5. Goblet cell carcinoid of the appendix: a specific type of carcinoma. van Eeden S; Offerhaus GJ; Hart AA; Boerrigter L; Nederlof PM; Porter E; van Velthuysen ML Histopathology; 2007 Dec; 51(6):763-73. PubMed ID: 18042066 [TBL] [Abstract][Full Text] [Related]
6. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium. Enomoto T; Fujita M; Inoue M; Rice JM; Nakajima R; Tanizawa O; Nomura T Cancer Res; 1993 Apr; 53(8):1883-8. PubMed ID: 8385572 [TBL] [Abstract][Full Text] [Related]
7. Morphological-histochemical study of intestinal carcinoids and K-ras mutation analysis in appendiceal carcinoids. Paraskevakou H; Saetta A; Skandalis K; Tseleni S; Athanassiadis A; Davaris PS Pathol Oncol Res; 1999; 5(3):205-10. PubMed ID: 10491018 [TBL] [Abstract][Full Text] [Related]
8. Sequential accumulation of K-ras mutations and p53 overexpression in the progression of pancreatic mucinous cystic neoplasms to malignancy. Jimenez RE; Warshaw AL; Z'graggen K; Hartwig W; Taylor DZ; Compton CC; Fernández-del Castillo C Ann Surg; 1999 Oct; 230(4):501-9; discussion 509-11. PubMed ID: 10522720 [TBL] [Abstract][Full Text] [Related]
9. EGFR, KRAS, BRAF-mutations and microsatellite instability are absent in goblet cell carcinoids of the appendix. Dimmler A; Geddert H; Faller G Pathol Res Pract; 2014 May; 210(5):274-8. PubMed ID: 24560515 [TBL] [Abstract][Full Text] [Related]
10. The presence of K-12 ras mutations in duodenal adenocarcinomas and the absence of ras mutations in other small bowel adenocarcinomas and carcinoid tumors. Younes N; Fulton N; Tanaka R; Wayne J; Straus FH; Kaplan EL Cancer; 1997 May; 79(9):1804-8. PubMed ID: 9128999 [TBL] [Abstract][Full Text] [Related]
11. Mutational landscape of goblet cell carcinoids and adenocarcinoma ex goblet cell carcinoids of the appendix is distinct from typical carcinoids and colorectal adenocarcinomas. Johncilla M; Stachler M; Misdraji J; Lisovsky M; Yozu M; Lindeman N; Lauwers GY; Odze RD; Srivastava A Mod Pathol; 2018 Jun; 31(6):989-996. PubMed ID: 29422640 [TBL] [Abstract][Full Text] [Related]
12. Combined classical carcinoid and goblet cell carcinoid tumor: a new morphologic variant of carcinoid tumor of the appendix. Chetty R; Klimstra DS; Henson DE; Albores-Saavedra J Am J Surg Pathol; 2010 Aug; 34(8):1163-7. PubMed ID: 20631606 [TBL] [Abstract][Full Text] [Related]
14. Analysis of K-ras, N-ras, H-ras, and p53 in lung neuroendocrine neoplasms. Couce ME; Bautista D; Costa J; Carter D Diagn Mol Pathol; 1999 Jun; 8(2):71-9. PubMed ID: 10475381 [TBL] [Abstract][Full Text] [Related]
15. p53 and ras mutations in Ewing's sarcoma. Radig K; Schneider-Stock R; Röse I; Mittler U; Oda Y; Roessner A Pathol Res Pract; 1998; 194(3):157-62. PubMed ID: 9587933 [TBL] [Abstract][Full Text] [Related]
16. Ki-ras gene mutations are invariably present in low-grade mucinous tumors of the vermiform appendix. Zauber P; Berman E; Marotta S; Sabbath-Solitare M; Bishop T Scand J Gastroenterol; 2011 Jul; 46(7-8):869-74. PubMed ID: 21443421 [TBL] [Abstract][Full Text] [Related]
17. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women. Gealy R; Zhang L; Siegfried JM; Luketich JD; Keohavong P Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):297-302. PubMed ID: 10207632 [TBL] [Abstract][Full Text] [Related]
19. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance. Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410 [TBL] [Abstract][Full Text] [Related]
20. K-ras codon 12 and p53 mutations in biopsy specimens and bile from biliary tract cancers. Itoi T; Takei K; Shinohara Y; Takeda K; Nakamura K; Horibe T; Sanada A; Ohno H; Matsubayashi H; Saito T; Watanabe H Pathol Int; 1999 Jan; 49(1):30-7. PubMed ID: 10227722 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]